Manchester Intermittent versus Daily Diet App Study ( MIDDAS ): A pilot randomized controlled trial in patients with type 2 diabetes

医学 减肥 随机对照试验 置信区间 2型糖尿病 超重 安慰剂 肥胖 内科学 糖尿病 内分泌学 替代医学 病理
作者
Sarah McDiarmid,Michelle Harvie,Rhona Johnson,Avni Vyas,Azza Aglan,Jacqui Moran,Helen Ruane,Amanda Hulme,Katharine Sellers,Basil Issa
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:24 (3): 432-441 被引量:19
标识
DOI:10.1111/dom.14592
摘要

AIMS: To test the feasibility and potential efficacy of remotely supported intermittent low-energy diets (ILEDs) and continuous low-energy diets (CLEDs) in people with type 2 diabetes (T2D) and the feasibility of a randomized controlled trial comparing the two approaches. MATERIALS AND METHODS: Seventy-nine adults with overweight/obesity and T2D (≤8 years duration) were randomized 1:1 to CLED (8 weeks/56 days of daily Optifast 820 kcal (3430 kJ) diet) or isoenergetic ILED (2 days of Optifast and 5 days of a Mediterranean diet/week for 28 weeks). Weight maintenance/continued weight loss was undertaken for the remainder of the 52 weeks. Both groups received frequent telephone or the Oviva app support. Feasibility outcomes included study uptake, retention, app usage, dietary adherence, weight loss and change in glycated haemoglobin (HbA1c) at 52 weeks. RESULTS: We enrolled 39 ILED and 40 CLED participants and 27 (69%) ILED and 30 CLED (75%) attended the 52-week follow-up. Eighty-nine per cent (70 of 79) started using the app and 86% (44 of 51) still used the app at 52 weeks. Intention-to-treat analysis at 52 weeks showed percentage weight loss was mean (95% confidence interval) -5.4% (-7.6, -3.1%) for ILED and -6.0% (-7.9, -4.0%) for CLED. HbA1c <48 mmol/mol was achieved in 42% of both groups. Mean (95% confidence interval) changes in the T2D medication effect score were 0.0008 (-0.3, 0.3) for ILED and -0.5 (-0.8, -0.3) for CLED. CONCLUSION: The study shows the feasibility and potential efficacy of remotely delivered ILED and CLED programmes for weight loss and HbA1c reduction, and the feasibility of a randomized controlled trial comparing the two approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小蘑菇的应助被Lawer采纳,获得10
1秒前
Jasper的应助被方卓采纳,获得10
2秒前
1234完成签到,获得积分10
3秒前
birdy发布了新的文献求助10
3秒前
3秒前
4秒前
xingyuLi完成签到,获得积分20
5秒前
5秒前
小点点发布了新的文献求助20
7秒前
qducly2026完成签到,获得积分10
7秒前
打打的应助被泥猴桃采纳,获得10
8秒前
落羽发布了新的文献求助10
9秒前
张菁发布了新的文献求助10
9秒前
Zhou完成签到,获得积分10
9秒前
10秒前
11秒前
ding的应助被张琪培采纳,获得10
11秒前
七禾发布了新的文献求助10
12秒前
复杂代萱发布了新的文献求助10
12秒前
zhiwei发布了新的文献求助10
14秒前
14秒前
zhang5657发布了新的文献求助10
15秒前
15秒前
汉堡包的应助被OOOorange采纳,获得10
16秒前
16秒前
i坤发布了新的文献求助10
16秒前
共享精神的应助被Aboc采纳,获得10
16秒前
Mr.Jian完成签到,获得积分0
17秒前
方卓发布了新的文献求助10
17秒前
司徒元瑶完成签到 ,获得积分10
17秒前
18秒前
5kywa1ker发布了新的文献求助10
18秒前
18秒前
vivi完成签到,获得积分10
19秒前
简单生活发布了新的文献求助10
19秒前
20秒前
龙飞发布了新的文献求助10
20秒前
落羽完成签到,获得积分10
20秒前
隐形曼青的应助被如意的小凡采纳,获得50
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183381
求助须知:如何正确求助?哪些是违规求助? 9572627
关于积分的说明 21826833
捐赠科研通 7780405
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558177
邀请新用户注册赠送积分活动 2480309